Breast cancer drug developer Olema charts $100M IPO
October 30, 2020 at 18:00 PM EDT
The San Francisco company started a clinical trial in August for its experimental metastatic breast cancer drug.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|